Literature DB >> 30734044

Potential New Horizons for the Prevention of Cerebrovascular Diseases and Dementia.

Leonardo Pantoni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30734044     DOI： 10.1001/jamaneurol.2018.4406

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  4 in total

1.  Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.

Authors:  Chi-Hung Liu; Pi-Shan Sung; Yan-Rong Li; Wen-Kuan Huang; Tay-Wey Lee; Chin-Chang Huang; Tsong-Hai Lee; Tien-Hsing Chen; Yi-Chia Wei
Journal:  PLoS Med       Date:  2021-07-19       Impact factor: 11.069

2.  Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study.

Authors:  Chi-Hung Liu; Tsong-Hai Lee; Yu-Sheng Lin; Pi-Shan Sung; Yi-Chia Wei; Yan-Rong Li
Journal:  Cardiovasc Diabetol       Date:  2020-01-07       Impact factor: 9.951

3.  Association Between Hyperhomocysteinemia Combined with Metabolic Syndrome and Higher Prevalence of Stroke in Chinese Adults Who Have Elevated Blood Pressure.

Authors:  Feng Hu; Shichao Yu; Juan Li; Wei Zhou; Tao Wang; Xiao Huang; Huihui Bao; Xiaoshu Cheng
Journal:  Med Sci Monit       Date:  2022-01-11

4.  Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case-control study.

Authors:  Junghee Ha; Dong-Woo Choi; Keun You Kim; Chung Mo Nam; Eosu Kim
Journal:  Cardiovasc Diabetol       Date:  2021-07-27       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.